Peptide fusion inhibitors were designed based on the discovery that two homologous domains in the viral gp41 protein must interact with each other to promote fusion, and that mimicry of one of these domains by a heterologous protein can bind and disrupt the intramolecular interactions of the virus protein.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}